DeepMatter Group PLC Collaboration with the University of Cambridge (6277H)
August 05 2021 - 1:00AM
UK Regulatory
TIDMDMTR
RNS Number : 6277H
DeepMatter Group PLC
05 August 2021
5 August 2021
DeepMatter Group Plc
("DeepMatter" or the "Company" or the "Group")
DeepMatter collaborates with the University of Cambridge's
Innovation Centre in Digital Molecular Technologies
DeepMatter (AIM: DMTR), the AIM-quoted company focusing on
digitising chemistry, has commenced a project with the University
of Cambridge's Innovation Centre in Digital Molecular Technologies
(iDMT), an open innovation research centre co-funded by the
University of Cambridge, AstraZeneca, Shionogi, and the European
Regional Development Fund.
DeepMatter will provide its DigitalGlassware(R) platform to iDMT
as part of the development of a fully digital workflow in the
discovery and development of new molecules, materials, reactions
and processes.
This initiative is part of DeepMatter's ongoing programme to be
closely involved with key opinion leaders in the major
universities' emerging digital chemistry units and follows on from
its collaborations with the Universities of Leeds, Glasgow,
Sheffield and Nottingham.
The iDMT is a new initiative set up to enable the transformation
of chemistry into the fully digital domain including the increased
usage of data science, data standardisation, algorithms for
discovery and development, automated analytical chemistry, and
robotic equipment.
The iDMT supports collaborative research projects with small and
medium enterprises (SMEs) from across the UK, aiming to develop a
technology base to support the emerging digital economy in the
third largest manufacturing sector in the UK.
DigitalGlassware(R) comprises a cloud-based software platform
allowing scientists to easily bring together digitised synthesis
protocols (recipes) and contextualised time-course sensor streams
from a range of analytical instrumentation, importantly in
real-time.
The project will be based in the Yusuf Hamied Department of
Chemistry within the University of Cambridge and led by Alexei
Lapkin, Professor of Sustainable Reaction Engineering at the
University.
Mark Warne, CEO of DeepMatter Group, commented: " This is
another important step in rolling out our flagship platform
DigitalGlassware(R), with the key opinion leaders in the academic
world allowing us to demonstrate publicly its ability to discover
new molecules and routes to molecules in a way that would not
otherwise be able. The expertise we can garner by engaging with
these influential institutions will be invaluable in helping us to
innovate our platform even further.
"We are now establishing DigitalGlassware(R) as the go-to
platform for capturing and structuring time-course sensor data in
the lab, to enable improved insights for better productivity and
discovery.
"The establishment of iDMT is an exciting development for our
industry, aiming to spark a digital transformation in the chemical
industries. We have a shared focus on data capture and
standardisation, data science and robotics and we are looking
forward to working within the digital chemistry space at one of the
world's leading universities."
For more information, please contact:
DeepMatter Group plc T: 0141 548 8156
Mark Warne, Chief Executive Officer
C anaccord Genuity Limited (Nominated Advisor T: 020 7523 8000
and Broker)
Bobbie Hilliam
Alma PR T: 020 3405 0205
Caroline Forde / Harriet Jackson / Kieran deepmatter@almapr.co.uk
Breheny/ Faye Calow
About DeepMatter Group plc
DeepMatter is building and commercialising the most powerful
data platforms, to enable scientists to easily perform and optimise
chemical reactions, by increasingly integrating chemistry with
technology. Ultimately this will allow the greater use of
artificial intelligence and reaching a point where chemicals can be
autonomously synthesised through robotics.
Visit: www.deepmatter.io and follow @deepmattergroup
About iDMT
The Innovation Centre in Digital Molecular Technologies (iDMT)
is an open innovation platform for collaborative R&D projects
in the areas of artificial intelligence in molecular technologies,
robotic equipment for chemical synthesis, and algorithms and tools
for digital process development. The mission of the iDMT is to
support UK SMEs in the rapid development and testing of new
products and services for the evolving paradigm of the digital
economy, specifically in the sectors of chemical synthesis of
molecules and materials. The iDMT is co-funded by the University of
Cambridge, AstraZeneca, Shionogi and European Regional Development
Fund (ERDF).
Visit www.idmt.online and follow @iDMTcambridge
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCDBGDIRGGDGBS
(END) Dow Jones Newswires
August 05, 2021 02:00 ET (06:00 GMT)
Deepmatter (LSE:DMTR)
Historical Stock Chart
From Apr 2024 to May 2024
Deepmatter (LSE:DMTR)
Historical Stock Chart
From May 2023 to May 2024